RELATION BETWEEN PLATINUM-DNA ADDUCTS AND COMPLETE REMISSION IN ADULT ACUTE NONLYMPHOCYTIC LEUKEMIA

被引:4
作者
ARMSTRONG, SG
BROWMAN, GP
BENGER, AM
MEYER, RM
MCKAY, KL
SINGH, G
机构
[1] MCMASTER UNIV,HAMILTON CIV HOSP,HAMILTON REG CANC CTR,ONTARIO CANC TREATMENT & RES FDN,HAMILTON L8V 5C2,ON,CANADA
[2] MCMASTER UNIV,HAMILTON CIV HOSP,HAMILTON REG CANC CTR,ONTARIO CANC TREATMENT & RES FDN,DEPT MED,HAMILTON L8V 5C2,ON,CANADA
[3] MCMASTER UNIV,HAMILTON CIV HOSP,HAMILTON REG CANC CTR,ONTARIO CANC TREATMENT & RES FDN,HAMILTON L8V 5C2,ON,CANADA
关键词
ACUTE LEUKEMIA; PLATINUM-DNA ADDUCTS; REMISSION PREDICTION;
D O I
10.1016/0145-2126(94)90064-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to determine the relationship between platinum-DNA adducts in leukemic cells and the success of remission induction therapy in adult patients with acute nonlymphocytic leukemia (ANLL). Freshly isolated cells from pre-treatment bone marrow aspirates of 14 patients were incubated with cisplatin in vitro and the amount of platinum bound to DNA was determined using a competitive ELISA procedure and an antibody directed against platinum-modified DNA. Platinum-DNA adduct levels discriminated well between complete remission (CR) and remission failure (RF) patients, treated with mitoxantrone, cytosine arabinoside +/- carboplatin.
引用
收藏
页码:659 / 664
页数:6
相关论文
共 39 条
[21]  
MASUDA H, 1990, CANCER RES, V50, P1863
[22]  
MAYER RJ, 1987, SEMIN ONCOL, V14, P384
[23]   PLATINUM DNA DAMAGE IN LEUKOCYTE DNA OF PATIENTS RECEIVING CARBOPLATIN AND CISPLATIN CHEMOTHERAPY, MEASURED BY ATOMIC-ABSORPTION SPECTROMETRY [J].
PARKER, RJ ;
GILL, I ;
TARONE, R ;
VIONNET, JA ;
GRUNBERG, S ;
MUGGIA, FM ;
REED, E .
CARCINOGENESIS, 1991, 12 (07) :1253-1258
[24]   ACQUIRED CISPLATIN RESISTANCE IN HUMAN OVARIAN-CANCER CELLS IS ASSOCIATED WITH ENHANCED REPAIR OF CISPLATIN-DNA LESIONS AND REDUCED DRUG ACCUMULATION [J].
PARKER, RJ ;
EASTMAN, A ;
BOSTICKBRUTON, F ;
REED, E .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) :772-777
[25]   ANTIBODIES ELICITED AGAINST CIS-DIAMMINEDICHLOROPLATINUM(II)-MODIFIED DNA ARE SPECIFIC FOR CIS-DIAMMINEDICHLOROPLATINUM(II)-DNA ADDUCTS FORMED INVIVO AND INVITRO [J].
POIRIER, MC ;
LIPPARD, SJ ;
ZWELLING, LA ;
USHAY, HM ;
KERRIGAN, D ;
THILL, CC ;
SANTELLA, RM ;
GRUNBERGER, D ;
YUSPA, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (21) :6443-6447
[26]   RECOGNITION OF DRUG-RESISTANCE DURING REMISSION INDUCTION THERAPY FOR ACUTE NON-LYMPHOCYTIC LEUKEMIA - UTILITY OF DAY 6 BONE-MARROW BIOPSY [J].
PREISLER, H ;
BARCOS, M ;
REESE, P ;
PRIORE, RL ;
POTHIER, L .
LEUKEMIA RESEARCH, 1983, 7 (01) :67-&
[27]   FAILURE OF REMISSION INDUCTION IN ACUTE MYELOCYTIC-LEUKEMIA [J].
PREISLER, HD .
MEDICAL AND PEDIATRIC ONCOLOGY, 1978, 4 (03) :275-276
[28]  
REED E, 1990, CANCER RES, V50, P2256
[29]  
REED E, 1993, CANCER RES, V53, P3694
[30]   PLATINUM-DNA ADDUCTS IN LEUKOCYTE DNA CORRELATE WITH DISEASE RESPONSE IN OVARIAN-CANCER PATIENTS RECEIVING PLATINUM-BASED CHEMOTHERAPY [J].
REED, E ;
OZOLS, RF ;
TARONE, R ;
YUSPA, SH ;
POIRIER, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (14) :5024-5028